Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind multicenter study of nifuratel + nystatin vaginal soft capsules for vulvovaginal candidiasis
CTR20263843Phase 3Active
- Sponsor
- Guangdong Hengjian Pharmaceutical
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifuratel in vulvovaginal candidiasis (VVC), sponsored by Guangdong Hengjian Pharmaceutical. Started Oct 2026; status: active.
02
Drugs
nifuratel
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on CTR20263843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263843.